Intersect ENT (XENT) Tops Q2 EPS by 3c

Intersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.23), $0.03 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.74 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Parsons Corporation (PSN) Tops Q2 EPS by 10c; Offers Guidance
• Natural Health Trends (NHTC) Misses Q2 EPS by 5c
• Benchmark Reiterates Hold Rating on Warner Brothers Discovery (WBD)